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Polyarteritis nodosa (PAN) of the breast is a rare condition where literature review identiﬁed eleven
patients so far. The clinical presentation ranged from localized disease involving the breast parenchyma
and skin only to breast manifestations as part of systemic PAN. The diagnosis of PAN could be challenging
as it can mimic breast cancer, inﬂammatory carcinomatosis or breast infection including mastitis and
necrotizing fasciitis. The key importance is accurate diagnosis to avoid unnecessary other treatment
modalities and the timely recognition of PAN in cases of localized forms. The authors present three new
cases which represent the full range of the clinical spectrum and their management.
 2009 Published by Elsevier Ltd on behalf of Surgical Associates Ltd.1. Introduction
Polyarteritis Nodosa (PAN) belongs to a group of inﬂammatory
disorders characterized by necrotizing vasculitis of small and
medium sized blood vessels.1 Whether systemic or focal in
appearance all manifestations share histopathological ﬁndings of
arteritis.2 The term PAN presently includes classic PAN, cutaneous
PAN andmicroscopic PAN (microscopic polyangiitis [MPA]).2 Multi-
organ involvement is more common than isolated organ involve-
ment.3 PAN affecting the breast alone has been reported in very few
patients. To date, eleven patients with PAN involving the breast
have been reported in the medical literature.1,3–11 In those it pre-
sented as an isolated vasculitis of the parenchymatous mammary
tissue, as cutaneous PAN lesions of the breast skin envelope with
involvement of breast ﬁbro-glandular tissue, or ﬁnally as involve-
ment of the glandular mammary tissue as part of the systemic
classic PAN.atology; CHCC, Chapel Hill
; PAN, Polyareteritis Nodosa;
CA Associated Vasculitis; AIP,
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Elsevier Ltd on behalf of Surgical AWe here present further 3 cases of breast PAN with different
presentation including literature review and differential diagnosis.
2. Patients and methods
Case 1. A 21-year-old Afro-Caribbean multi-paraous woman
presented to the breast care unit in 2004 with a sudden onset
necrotizing skin lesion involving the central, upper and lower
lateral quadrants of left breast leading to inﬂammatory, hyperpig-
mented, tender skin changes (Fig. 1a). She concomitantly suffered
from a gangrene of the dorsum and the distal small ﬁnger of the left
hand. Medical history revealed sickle cell disease with recurrent
deep venous thrombosis, retinopathy and pulmonary hypertension.
The clinical differential diagnosis at that time contained a non-
lactational breast abscess, inﬂammatory carcinomatosis, necro-
tizing fasciitis and sickle cell crisis. Generalised sepsis urged
a thorough surgical debridement of necrotic tissues with use
empirical antibiotics. Surgical debridement revealed full thickness
infarction of the skin and underlying breast parenchyma. Delayed
second stage coverage of the defect was performed using a meshed
split thickness graft (5 days). Light microscopy and culture of the
removed breast tissue failed to detect an organism. Histopathology
revealed extensive vasculitis of small and medium sized vessels
with ﬁbrinoid necrosis of vessel walls in absence of malignancy
(Fig. 1b). Blood cultures to exclude septic emboli proved to bessociates Ltd.
Fig. 1. (a) Intraoperative picture showing areas of necrosis with surrounding zone of erythema and cellulites of the left breast skin envelope mimking inﬂammatory mastitis, abscess
or inﬂammatory carcinomatosis. (b) Microscopic picture of adipo-ﬁbro-glandular tissue showing small to medium sized vessels with ﬁbrinoid necrosis, acute inﬂammation and
thrombotic occlusion of lumen, Elastic Van Gieson (EVG)100 HPF stain conﬁrmed vessels to be arteries rather than veins (arrow a), mammary ducts in the vicinity (arrow b). No
granulomas were seen excluding granulomatous vasculiltis, e.g. Wegener’s granulomatosis.
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rheumatology team for further evaluation with immunological and
inﬂammatory workup which are shown in Table 1. The patient was
subsequently diagnosed with microscopic PAN (MPA) where anti-
proteinase 3 (PR3) Antineutrophilic Cytoplasmic Antibody (ANCA)
was positive; she was started on corticosteriod therapy and
azathioprine which achieved complete remission. Hospital stay
was prolonged due to delayed wound healing. One year later she
developed leg ulcers, which healed on steroid therapy. No further
vasculitic episodes have been encountered since.
Case 2. A 45-year-old Asian woman noticed the spontaneous
appearance of a painless lump in the upper outer quadrant of the
left breast with a progressive course over a week’s time. Clinical
examination revealed a well deﬁned 2.5 cm non-tender lump
which felt equivocal. Mammogram found a non-suspicious ﬁbro-
glandular parenchyma pattern, while ultrasound revealed a 2.0 cm
complex cyst with internal echoes of low signal intensity and
a rather irregular thickened capsule. These features were initially
interpreted as a complex cyst or necrotic tumour (Fig. 2a). CoreTable 1
CASE 1 CASE 2 CASE 3
A. Clinical presentation (ACR) Absent Absent Present
B. Immunological and inﬂammatory markers:
1. Rheumatoid Factor (<20.0 lu/ml) 42a 9.7 10.1
2. Immunoglobulins
IgG (7.00–18.60 g/l) 20.8b b 24.20a
IgA (0.78–4.80 g/l) b b 9.37a
IgM (0.49–2.00 g/l) b b b
3. Antineutrophil Cytoplasmic
Antibody (ANCA)
Positive Negative Positive
4. Other Auto-Antibodies
AntiMitochondrial antibody Negative Negative Negative
Anti Gastric Parietal Cell Antibody Negative Negative Negative
Liver Kidney Microsome Negative Negative Negative
Anti-smooth Muscle Antibodies Negative Negative Positive
Double stranded Autoantibodies Negative Negative Negative
5. C Reactive Protein (CRP)< 5 mg/L 267.1a b 277a
6. Erythrocyte sedimentation rate (ESR) Raised Not raised Raised
7. Complement
C3 (0.70–1.65 g/l) 1.74a b b
C4 (0.16–0.54 g/l) 0.13c b b
C. Histopathology results Conﬁrms
PAN
Conﬁrms
PAN
Conﬁrms
PAN
a High.
b Normal.
c Low.needle biopsy revealed necrosis and inﬂammatory granulation
tissue insufﬁcient for complete histological analysis. Histopa-
thology of the excisional biopsy of the nodule then revealed
a localized form of healed arteritis (Fig. 2b). Immunohistochemical
staining for cytokeratinMNF 116was negative and special stains for
organisms were all negative. No further management was provided
for the patient whowas referred for follow-up andmore evaluation
by the rheumatology team where immunological and inﬂamma-
tory workup was performed (Table 1).
Case 3. This 50 years old Afro-Caribbean woman had a remark-
able medical background. She was known to suffer from acute
intermittent porphyria AIP with renal failure and secondary
hyperparathyroidism cured by total parathyroidectomy in 2006.
She presented with bilateral extensive necrotic leg ulcers initially
thought to represent cutaneous calciphylaxis despite a low or
normal calcium phosphate product (Fig. 3a). Multiple skin biopsies
failed to prove PAN. The disease rapidly progressed in bouts which
weremirrored by extreme elevations of CRP and ESR. Table 1 shows
the immunological and inﬂammatory markers. The diagnosis was
ﬁnally made by elevated ANCA titres. Major visceral haemorrhage
led to angiography demonstrating typical aneurysmata of the
middle sized visceral arterial branches with active bleeding of one
of these lesions. During her prolonged admission over 7 months
repeated surgical debridement became necessary for management
of these extensive gangrenous areas in both lower limbs. Partially
these were covered by mesh grafts. Whilst the initial presentation
involved the lower body half only, she then presented with acute
onset bilateral breast tenderness in the late course of her disease.
On clinical examination, both breasts were tender, though without
signiﬁcant abnormality apart from symmetrical thickening of the
ﬁbro-glandular tissue and dilated superﬁcial veins. Mammogram
revealed marked vascular calciﬁcations seen throughout both
breasts with focal areas of benign, dense clusters of calciﬁcation,
but no focal masses (Fig. 3b). Bilateral breast ultrasound was non-
speciﬁc revealing inﬂamed ﬁbro-glandular tissue in the retro-
areolar region, but no evidence of focal collections to suggest an
abscess or any other focal abnormality. Computed tomography scan
showed areas of calciﬁcation in the glandular parenchyma. Core
needle biopsy of both breasts revealed ﬁbrinoid necrosis and whole
thickness inﬂammation of small and blood vessels giving the
appearances of small vessel vasculitis (Fig. 3c). The patient had at
that time been under the protocol high-dose management for PAN
according to ACR recommendations including cyclophosphamide,
azathioprine and corticosteroids. Unfortunately, the patient died
Fig. 2. (a) Ultrasound image showing a 20 mm poor echogenic mass in left breast contains some ﬂuid with internal echoes thicked capsule with a provisional diagnosis of a complex
cyst and a necrotic tumour, it was graded as U4 (suspicious mass). (b) Microscopic picture showing vasculitic changes in breast PAN. One of the main microscopic features includes
focal destruction of elastic lamina which could be demonstrated using special elastic tissue staining elastic Van Gieson (EVG)200 HPF. Intimal thickening and recanalized
thrombosis are characteristics of healed arteritis.
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one month later.
3. Discussion
Breast involvement is a rare site of apparently localized vascu-
litis; it can either be granulomatus or necrotizing in nature.4 Our
cases demonstrate that it may be more common than expected
when a high index of suspicion is used in the diagnostic approach.
Diagnosis relies on histopathological examination of representative
tissue specimen and the use of highly speciﬁc immunological tests
in patients with suspicious features. These diagnostic modalities
should be performed in all patients with an otherwise unexplained
inﬂammatory change of the breast – even if systemic manifesta-
tions are lacking at that point. The key importance of such an
approach is the avoidance of unnecessary other treatment modal-
ities and the timely recognition of PAN. As seen here, breast
manifestations can be amongst the ﬁrst clinical manifestations and
an accurate diagnosis is the key to initial and long-term manage-
ment of this rare yet devastating disease. Multiple studies prove
that such early diagnosis of PAN can reduce both mortality and
morbidity due to the disease.12
It is clinically of prime importance to differentiate between
isolated and systemic PAN which mainly depends on the exclusion
of visceral involvement as isolated form has a much more favour-
able prognosis.4
Review of the literature shows that PAN of the breast presents as
a localized isolated lesion or part of systemic disease that includeFig. 3. (a) Bilateral lower limb extensive vasculitic necrotic ulcers involving cutaneous and s
radial calciﬁcation as part of systemic PAN. Differential diagnosis of radial calciﬁcation includ
PAN (H & E)100 HPF showing vasculitis associated with ﬁbrinoid necrosis. One of the charac
inﬁltrates within the breast parenchyma.visceral involvement.1,3–11 All three cases share the involvement of
the glandular breast tissue in the inﬂammatory process. They
demonstrate the three clinical manifestations of PAN in the breast:
- a breast nodule, with or without other cutaneous or systemic
ﬁndings;
- full thickness skin necrosis and necrosis of underlying soft
tissues in the setting of multi-focal cutaneous vasculitis;
- Predominantly systemic PAN with involvement of the breast.
The glandular tissue of the breast is an exocrine organ. PAN has
been previously reported to involve isolated organs including other
exocrine organs such as appendix,13 gallbladder,14 cervix,15 epi-
pdidymis,16 alimentary canal,17,18 pancreas,19 salivary glands,20
prostate.21
Arteritis could either affect the mammary tissue or the over
lying skin and subcutaneous tissue (cutaneous PAN). These distinct
entities of the disease should not be confused as cutaneous PAN is
associated with good prognosis.7,22,23 Review of the literature
revealed only one case that presented with a tender breast mass,
ulceration and central necrosis and erythematosus tender necrotic
nodules in the legs and the arms. Clinically this was interpreted as
a multi-focal cutaneous PAN with isolated mammary tissue PAN at
the age of 34 postpartum with the presumptive diagnosis as
puerperal mastitis.4 The ﬁrst case in this series presented with the
similar clinical manifestations but not related to pregnancy or
lactation and at a younger age (21 years). We have failed to ﬁnd
evidence that PAN of the breast is induced by or related to lactation.ubcutaneous tissue as part of systemic PAN. (b) Bilateral mammogram showing focal &
es atherosclerosis, comedo mastitis and calciphylaxis. (c) Microscopic picture of breast
ters is the presence of acute and chronic inﬂammatory cells (neutrophils, lymphocytes)
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mammary tissue PAN with no systemic signs or constitutional
manifestations.1,9–11 The reported age in this group ranged from 45
to 78 years. All the lesions were tender ﬁrm breast mass with
reported size between 2 and 5 cm. except one casewhich presented
with a non-tender lump1 that was clinically suspicious for cancer;
four cases were unilateral, whilst one was bilateral. The second case
in this series presented with a 25 mm non-tender ﬁrm mass which
was clinically suspicious mimicking cancer. This underscores that
localized breast PAN may simulate malignancy, as in any other
organ. It should be part of the differential diagnosis of breast cancer
and to be subjected to triple assessment. The relationship of breast
arteritis in general and breast cancer is unknown. There is only one
case diagnosed with arteritis and focal ﬁbrinoid necrosis as an
incidental ﬁnding during histopathological examination of the
breast tissue post-mastectomy for breast cancer in a patient with
known polymyalgia rheumatica.24
There are existing schemes for the classiﬁcation of vasculitis
which are widely used including American College of Rheuma-
tology (ACR)25 and Chapel Hill Consensus Conference (CHCC).26 Six
cases reported between 1968 and 1998 presented with mammary
PAN in association with typical constitutional symptoms of PAN
such as fatigue, headache, arthralgia, myalgia, and mild
pyrexia.5,6,7,8 Two of them fulﬁlled the American College of Rheu-
matology (ACR) criteria for classiﬁcation as systemic PAN.5,7 Their
age range was between 58 and 72 years, and they presented with
either unilateral (2 cases) or bilateral (4 cases) indurated tender
masses. It was not mentioned at which stage the breast became
involved leaving us with insufﬁcient data about the time course of
breast manifestations in the systemic course of the disease. The
third case in this series had suffered from severe systemic PAN for
a year where she died within weeks after the breasts were bilat-
erally clinically involved for the ﬁrst time throughout long
progression of the disease.
Imaging modalities made a relatively poor contribution to
establishing the diagnosis. Mammographic evaluation has not been
reported in all of the previously reported case. Those reported
revealed no evidence of malignancy, but in one case reported by
Orbo,11 calciﬁcation of the arteries was a prominent feature of both
breast X-rays, which was also observed in our third case showing
extensive radial calciﬁcations. Thin slice CT scan evaluation of the
breast revealed areas of radial calciﬁcation but couldn’t prove to be
superior over the mammogram in this particular case. In this rare
presentation it is also worth noting the differential diagnosis of
radial calciﬁcation which includes atherosclerosis of the older
population, comedo mastitis and calciphylaxis.27,28 Calciphylaxis
could be a cause of extensive calciﬁcation of vessels involving all
organs.28 In the third case, this has been excluded by normal PTH
and serum calcium. The radial calciﬁcations of breast tissue would
hence rather be a speciﬁc ﬁnding of severe PAN.
The laboratory abnormalities in PAN reﬂect the degree of the
inﬂammation and in systemic PAN according to the vascular
impairment of speciﬁc organs.4 The lack of speciﬁc serological tests
and immunological abnormalities are characteristic of PAN.29 The
ACR criteria for classiﬁcation of PAN are of proven value to diagnose
the systemic form of the disease.25 They are unlikely to be reliable
in localized forms.30 Table 1 shows the serological and immuno-
logical abnormalities in all 3 patients. ANCA is a marker of systemic
vasculitis, which might be positive in a few patients (10–20%) of
systemic PAN.2 In 1994 the CHCC recognized that histological data
would not be available in some patients due to clinical conditions
that would preclude obtaining appropriate biopsy or due to non-
representative histopathological features. This allowed the intro-
duction of the concept of surrogate markers and ANCA but was not
used in the deﬁnitions in either the ACR or CHCC.25,26,31 There hasbeen controversy in the classiﬁcation of the ANCA associated
vasculitis (AAV) including the MPA which was not included in ACR
classiﬁcation as patients classiﬁed as PAN by ACR may have been
MPA by CHCC.31 In this study ANCA titres were elevated in the two
patients with multi-focal cutaneous involvement and the systemic
form as show in Table 1. Although there is no clear data concerning
the ethnic background of PAN in general there have been some
epidemiological studies in the United States and Europe which
demonstrated prediction and genetic susceptibility in white and
Caucasians.32,33 In this study, two patients were of afro-Caribbean
origin and one of Asian origin, where this reﬂect geographical/
ethnic difference or due to environmental factors it is unclear and
more data is needed to verify the epidemiological basis of PAN. The
differential diagnosis of vasculitis of the breast can be summarized
with respect to clinical, pathological and radiological terms as
outlined in the following algorithm:
*Take home message
Recently, two systems have been proposed for the nomenclature
of primary vasculitides: the 1990 American College of Rheuma-
tology (ACR) classiﬁcation criteria39 and the 1994 Chapel Hill
Consensus Conference (CHCC)40 deﬁnitions. The Chapel Hill deﬁ-
nitions are biopsy dependent and surrogate features for the
deﬁning histology are required to allow their practical application.
In concordance clinical examination and imaging investigation are
fairly non-speciﬁc for the diagnosis of breast PAN which leads to
a clinical dilemma. A high index of suspicious is required to reach
this difﬁcult diagnosis which could be summarized in the
following:
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involving the breast including the skin envelope.
2. Any patient presenting with breast lump and/or mastalgia with
one of the following:
a. Previous or concomitant presentation of inﬂammatory
cutaneous nodules including digital distal gangrene and or
livedo reticularis.
b. History of systemic PAN as classiﬁed by the ACR criteria.
c. Mammogram showing radial calciﬁcations.
Finally the high index of suspicious could be conﬁrmed by
histopathological examination with or without positive immuno-
logical and inﬂammatory laboratory test.
In conclusion, PAN of the breast is rare; however involvement of
the breast seems to be more frequent than that of other exocrine
glands. The main difﬁculty is to differentiate PAN of the breast from
mammary vasculitis in more general terms and from breast cancer.
The differentiation from necrotizing fascitis and acutely infective
condition is of the essence to correctly treat this disorders which
may rapidly lead to an extensive necrotic inﬂammatory process,
which may become life-threatening due to sepsis. Imaging and
laboratory examinations are of limited value and wherever the
suspicion of PAN is raised mainly a sufﬁcient tissue samplewill lead
to a histopathological diagnosis. Treatment is guided by the
presentation. Localized necrotic skin manifestation and necrosis of
mammary tissue are managed by surgical debridement and
management of the defect and immunosuppressive treatment
should only be commenced once a tissue diagnosis has conﬁrmed
PAN. Non-tender ﬁrm masses of the breast should undergo triple
assessment by core needle biopsy. Conﬁrmation of PAN should then
lead to an early referral to the rheumatology team for further
evaluation, and immunosuppressive therapy as timely evaluation of
the systemic impact of the disease is a key factor in the prognosis.
The role of excisional therapy for localized forms of PAN is not
sufﬁciently understood. PAN is primarily a systemic disease. In the
perspective of the Breast Clinician it remains a rare but important
differential diagnosis with serious impact on patient outcome.
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